Table of Contents PART 01: Executive summary PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Diabetes: One of the leading causes of ocular and cardiovascular diseases • Different technologies used in OCT systems PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Conventional OCT systems • Hand-held integrated OCT systems PART 07: Market segmentation by application • Ophthalmology • Dermatology • Dentistry • Cardiology PART 08: Market segmentation by end-users • Hospitals and clinics • ASCs • Physicians' offices PART 09: Geographical segmentation • OCT market in Americas • OCT market in EMEA • OCT market in APAC PART 10: Market drivers • Growing number of chronic diseases in aging population • Mergers and acquisitions of small specialized hospitals by Tier-1 hospitals • Market expansion by product differentiation in OCT PART 11: Impact of drivers PART 12: Market challenges • High investment and installation cost • Lack of reimbursement policies • Tissue penetration limiting the OCT imaging PART 13: Impact of drivers and challenges PART 14: Market trends • Advances in OCT by introducing newer techniques • Increasing government and investor funding • Rise in demand for radiation free devices in oncology PART 15: Vendor landscape • Competitive landscape PART 16: Key vendor analysis • Carl Zeiss • Heidelberg Engineering • Leica Microsystems • TOPCON • Key companies to watch • Other prominent vendors PART 17: Appendix • List of abbreviations List of Exhibits Exhibit 01: Product offerings Exhibit 02: Technologies used in OCT imaging technology Exhibit 03: New approach in OCT imaging technology Exhibit 04: Global OCT market 2016-2021 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global OCT market 2016 Exhibit 07: Market overview: Conventional OCT systems Exhibit 08: Market overview: Hand-held integrated OCT systems Exhibit 09: Global OCT market by application 2016 Exhibit 10: Market overview: Ophthalmology Exhibit 11: Market overview: Dermatology Exhibit 12: Market overview: Dentistry Exhibit 13: Market overview: Cardiology Exhibit 14: Global OCT market by end-users 2016 Exhibit 15: Buying criteria of end users for OCT systems Exhibit 16: Global OCT market in 2016 and 2021 ($ millions) Exhibit 17: Market overview: OCT market in Americas Exhibit 18: OCT market in Americas 2016-2021 ($ millions) Exhibit 19: Present and future market scenario analysis: Optical imaging market in Americas Exhibit 20: Market overview: OCT market in US Exhibit 21: Market overview: OCT market in EMEA Exhibit 22: Diabetes hospital admission for adults in 2008 and 2013 (per 100,000 people) Exhibit 23: OCT market in EMEA 2016-2021 ($ millions) Exhibit 24: Present and future market scenario analysis: Optical imaging market in EMEA Exhibit 25: Market overview: OCT market in UK Exhibit 26: Market overview: OCT market in APAC Exhibit 27: OCT market in APAC 2016-2021 ($ millions) Exhibit 28: Present and future market scenario analysis: Optical imaging market in APAC Exhibit 29: Market overview: OCT market in Australia Exhibit 30: Percentage of global aging population aged 60+ years 2010-2050 Exhibit 31: Number of hospitals merged and acquired from 2010 to 2015 in US Exhibit 32: Impact of drivers Exhibit 33: Impact of drivers and challenges Exhibit 34: Government funding for OCT technology development Exhibit 35: Funding by investors for OCT technology development Exhibit 36: Competitive structure analysis of global OCT market 2016 Exhibit 37: Competitive landscape analysis of global OCT market in 2016 Exhibit 38: Ranking of key vendors in global OCT market 2016 (conventional OCT systems) Exhibit 39: Carl Zeiss: Strength assessment Exhibit 40: Carl Zeiss: Strategy assessment Exhibit 41: Carl Zeiss: Opportunity assessment Exhibit 42: Heidelberg Engineering: Strength assessment Exhibit 43: Heidelberg Engineering: Strategy assessment Exhibit 44: Heidelberg Engineering: Opportunity assessment Exhibit 45: Leica Microsystems: Strength assessment Exhibit 46: Leica Microsystems: Strategy assessment Exhibit 47: Leica Microsystems: Opportunity assessment Exhibit 48: TOPCON: Strength assessment Exhibit 49: TOPCON: Strategy assessment Exhibit 50: TOPCON: Opportunity assessment

Heidelberg Engineering, Carl Zeiss, TOPCON, Leica Microsystems, Agfa HealthCare, Agiltron, DermaLumics, Insight, Michelson Diagnostics, Moptim, NinePoint Medical, Oztec, PhotoniCare, Santec, Terumo, Tomophase, Thorlabs, and St. Jude Medical